ANI Pharmaceuticals (ANIP)

[LordDarley]

The 30 days for underwriters to pick up another 225,000 shares @ $50 each. Not clear if that has been exercised, but very bullish if so.

I'm also wondering who the buyers were for the $75M at $50/share.

Guggenheim delivered those buyers for 1.2M of the 1.5M shares. Good job by them, and their customers are either long term optimists or a bit annoyed.

To steer customers into a bad short term deal like this, Guggenhaim must be pretty convinced all will work out well. I note that it got a 6 month first refusal right to be lead managing underwriter, lead initial purchaser, lead placement agent and/or lead arranger in connection with any future ANIP equity offering in that period. Hmmm. What's next, I wonder?

(Data from the November 5 prospectus. Speculation and judgments, just mine.)